266 related articles for article (PubMed ID: 34174445)
21. Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM.
Qi T; Wang Y; Yang Y; Gao S; Liu J; Huang Q; Tian Y; Tang J; Zheng WV; Wang Y
Nat Chem Biol; 2024 Mar; 20(3):344-352. PubMed ID: 38052959
[TBL] [Abstract][Full Text] [Related]
22. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
[TBL] [Abstract][Full Text] [Related]
23. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
24. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
Hua K; Tao X; Han P; Wang R; Zhu JK
Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes.
Ilahibaks NF; Kluiver TA; de Jong OG; de Jager SCA; Schiffelers RM; Vader P; Peng WC; Lei Z; Sluijter JPG
J Extracell Vesicles; 2024 Jan; 13(1):e12389. PubMed ID: 38191764
[TBL] [Abstract][Full Text] [Related]
26. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
[TBL] [Abstract][Full Text] [Related]
27. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
[TBL] [Abstract][Full Text] [Related]
28. PAM-less plant genome editing using a CRISPR-SpRY toolbox.
Ren Q; Sretenovic S; Liu S; Tang X; Huang L; He Y; Liu L; Guo Y; Zhong Z; Liu G; Cheng Y; Zheng X; Pan C; Yin D; Zhang Y; Li W; Qi L; Li C; Qi Y; Zhang Y
Nat Plants; 2021 Jan; 7(1):25-33. PubMed ID: 33398158
[TBL] [Abstract][Full Text] [Related]
29. PAM-flexible genome editing with an engineered chimeric Cas9.
Zhao L; Koseki SRT; Silverstein RA; Amrani N; Peng C; Kramme C; Savic N; Pacesa M; Rodríguez TC; Stan T; Tysinger E; Hong L; Yudistyra V; Ponnapati MR; Jacobson JM; Church GM; Jakimo N; Truant R; Jinek M; Kleinstiver BP; Sontheimer EJ; Chatterjee P
Nat Commun; 2023 Oct; 14(1):6175. PubMed ID: 37794046
[TBL] [Abstract][Full Text] [Related]
30. Closely related type II-C Cas9 orthologs recognize diverse PAMs.
Wei J; Hou L; Liu J; Wang Z; Gao S; Qi T; Gao S; Sun S; Wang Y
Elife; 2022 Aug; 11():. PubMed ID: 35959889
[TBL] [Abstract][Full Text] [Related]
31. Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.
Yin H; Song CQ; Suresh S; Wu Q; Walsh S; Rhym LH; Mintzer E; Bolukbasi MF; Zhu LJ; Kauffman K; Mou H; Oberholzer A; Ding J; Kwan SY; Bogorad RL; Zatsepin T; Koteliansky V; Wolfe SA; Xue W; Langer R; Anderson DG
Nat Biotechnol; 2017 Dec; 35(12):1179-1187. PubMed ID: 29131148
[TBL] [Abstract][Full Text] [Related]
32. FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity.
Cui Z; Tian R; Huang Z; Jin Z; Li L; Liu J; Huang Z; Xie H; Liu D; Mo H; Zhou R; Lang B; Meng B; Weng H; Hu Z
Nat Commun; 2022 Mar; 13(1):1425. PubMed ID: 35301321
[TBL] [Abstract][Full Text] [Related]
33. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
Jarrett KE; Lee C; De Giorgi M; Hurley A; Gillard BK; Doerfler AM; Li A; Pownall HJ; Bao G; Lagor WR
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):1997-2006. PubMed ID: 30026278
[TBL] [Abstract][Full Text] [Related]
34. A truncated reverse transcriptase enhances prime editing by split AAV vectors.
Gao Z; Ravendran S; Mikkelsen NS; Haldrup J; Cai H; Ding X; Paludan SR; Thomsen MK; Mikkelsen JG; Bak RO
Mol Ther; 2022 Sep; 30(9):2942-2951. PubMed ID: 35808824
[TBL] [Abstract][Full Text] [Related]
35. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
36. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
[TBL] [Abstract][Full Text] [Related]
37. The SpRY Cas9 variant release the PAM sequence constraint for genome editing in the model plant Physcomitrium patens.
Calbry J; Goudounet G; Charlot F; Guyon-Debast A; Perroud PF; Nogué F
Transgenic Res; 2024 Apr; 33(1-2):67-74. PubMed ID: 38573428
[TBL] [Abstract][Full Text] [Related]
38. Improved Dual Base Editor Systems (iACBEs) for Simultaneous Conversion of Adenine and Cytosine in the Bacterium Escherichia coli.
Shelake RM; Pramanik D; Kim JY
mBio; 2023 Feb; 14(1):e0229622. PubMed ID: 36625577
[TBL] [Abstract][Full Text] [Related]
39. Points of View on the Tools for Genome/Gene Editing.
Chuang CK; Lin WM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
[TBL] [Abstract][Full Text] [Related]
40. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
